This commentary was published by Hai Fang from Peking University, Bryan Patenaude from John Hopkins University, and Chao Ma from China CDC in BMJ Global Health. The article introduced that China employs distinct pricing strategies for National Immunization Programme (NIP) and non-NIP vaccines, with low prices for NIP vaccines potentially posing challenges for integrating more expensive non-NIP vaccines. Applying volume-based procurement strategies might reduce the prices and address citizens’ need.
Factors affecting caregivers’ HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT
This research, led by Prof. Jing Li from Sichuan University, in collaboration with Prof. Dan Wu from Nanjing Medical University, was published in PLOS ONE. Based on a randomized controlled trial conducted in Chengdu, China, the study investigated key factors influencing caregivers’ actions to vaccinate adolescent girls against HPV. The results highlighted the significant role of a novel “pay-it-forward” intervention in doubling HPV vaccine uptake. Other factors, including caregivers’ knowledge, intention to delay vaccination, occupational status, and prior vaccine refusal, were also strongly associated with vaccination behavior. Recommendations to promote universal and equitable access to HPV vaccine through targeted health education, financial support and community engagement.
